Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 15, 2025. Document 2025-22763. Updated Nov. 16, 2026.

What it does

The Administrator of the Drug Enforcement Administration is issuing this notification of intent to publish a temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle bromazolam.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1308

What happens next and when

December 15, 2025.

The agency's dates, word for word.

Document number2025-22763
ActionProposed amendment; notification of intent.
AgenciesJustice Department; Drug Enforcement Administration
PublishedDec. 15, 2025
DocketDEA-2025-0885

Source: the Federal Register (public domain). The document in the Federal Register